
StayHappi Glimepiride 1mg Tablet
Marketer
Sarvagunaushdhi Pvt Ltd
Salt Composition
Glimepiride (1mg)
Overview StayHappi Glimepiride 1mg Tablet
Glimepiride 1mg tablets (StayHappi brand) are sulfonylurea medications treating type 2 diabetes in adults. They regulate blood glucose, mitigating severe diabetic complications like kidney failure and vision loss. This medication can be prescribed alone or in conjunction with other treatments. Administer it immediately before or with your first daily meal, consistently at the same time for optimal efficacy. Dosage is determined by your physician and may adjust based on your glucose levels. Continuous use of Glimepiride 1mg is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose, increasing the risk of diabetic nephropathy, blindness, neuropathy, and limb loss. Successful diabetes management requires a holistic approach encompassing diet, exercise, and weight management as guided by your doctor. Common adverse effects include hypoglycemia (low blood sugar), nausea, headache, weakness, and dizziness. Learn to identify hypoglycemia symptoms (sweating, dizziness, headache, trembling) and appropriate countermeasures, such as readily available glucose (sugary foods or juice). Alcohol consumption elevates hypoglycemia risk and should be avoided. Weight gain is a potential side effect. Glimepiride 1mg is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Disclose any history of heart disease, thyroid disorders, or hormonal imbalances before initiating treatment, as it may be unsuitable. Pregnant or lactating individuals require medical consultation prior to use. Regular blood glucose monitoring is necessary; your physician may order blood tests to track blood cell counts and liver function.
Uses of StayHappi Glimepiride 1mg Tablet
Managing type 2 diabetes
Major Benefits of StayHappi Glimepiride 1mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the StayHappi Glimepiride 1mg Tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.
Common Side effects of StayHappi Glimepiride 1mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Dizziness
- Weakness
How to use StayHappi Glimepiride 1mg Tablet:
Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The StayHappi Glimepiride 1mg Tablet should be administered with a meal.
How StayHappi Glimepiride 1mg Tablet works:
GlucoDown (Glimepiride 1mg) tablets help manage blood sugar. This medication stimulates the pancreas to produce more insulin, thus reducing glucose levels.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking StayHappi Glimepiride 1mg Tablet is dangerous.
PregnancyCONSULT YOUR DOCTOR
The use of StayHappi Glimepiride 1mg Tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing this medication. Physician consultation is recommended.
Breast feedingCONSULT YOUR DOCTOR
The use of StayHappi Glimepiride 1mg Tablets while breastfeeding is likely inadvisable. Preliminary human data indicates potential transfer of the medication into breast milk, posing a risk to the infant. Close observation of the nursing infant's blood glucose levels is recommended when the mother is taking StayHappi Glimepiride 1mg Tablets.
DrivingCAUTION
Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with kidney impairment should use Glimepiride 1mg tablets (StayHappi brand) cautiously, potentially requiring dosage modification. Consult a physician for guidance. Glimepiride 1mg tablets (StayHappi brand) are contraindicated in individuals with severe kidney disease due to the risk of severe, though potentially transient, hypoglycemia.
LiverCAUTION
Individuals with liver impairment should use Glimepiride 1mg tablets (StayHappi brand) cautiously, potentially requiring dose modification. Consult a physician for guidance. The medication is contraindicated in patients exhibiting severe hepatic dysfunction due to the risk of profound hypoglycemia, which may resolve gradually.
What if you forget to take StayHappi Glimepiride 1mg Tablet :
Omit the missed StayHappi Glimepiride 1mg Tablet dose and continue with your regular dosing schedule.
Facts to Know About StayHappi Glimepiride 1mg Tablet
| Label | Value |
|---|---|
| Chemical Classification | Advanced Sulfonylurea |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
